Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl (2S,4R)-4-(benzyloxy)-2-[(methanesulfonyloxy)methyl]pyrrolidine-1-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

348165-59-3

Post Buying Request

348165-59-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

348165-59-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 348165-59-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,8,1,6 and 5 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 348165-59:
(8*3)+(7*4)+(6*8)+(5*1)+(4*6)+(3*5)+(2*5)+(1*9)=163
163 % 10 = 3
So 348165-59-3 is a valid CAS Registry Number.

348165-59-3Relevant academic research and scientific papers

Chiral aminophosphines derived from hydroxyproline and their application in allene–imine [4 + 2] annulation

Khong, San N.,Xie, Changmin,Wang, Xinyi,Tan, Hao,Kwon, Ohyun

, p. 389 - 396 (2019)

A robust synthetic route from l-hydroxyproline (l-Hyp) to phosphines has established an expandable library of six chiral aminophosphines, which were then applied to the phosphine-catalyzed [4 + 2] allene–imine annulation. The enantioinduction in the annulations—induced by a purely steric effect—were moderate (up to 57% ee). A switch of the reaction site from the γ- to the β′-carbon atom of the allenoate was observed during the annulations performed using sterically demanding chiral phosphines.

INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES

-

, (2021/12/28)

Provided herein are heteroaryl inhibitors of fibroblast growth factor receptor kinases, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

1,2-DISUBSTITUTED-4-BENZYLAMINO-PYRROLIDINE DERIVATIVES AS CETP INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES SUCH AS HYPERLI PIDEMIA OR ARTERIOSCLEROSIS

-

Page/Page column 122, (2009/07/17)

The present invention provides a compound of formula (I): wherein the variants R1, R2, R3, R4, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 348165-59-3